Kenneth M. Attie
Kenneth M. Attie publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Hematology, on topics such as Growth Hormone and Insulin-like Growth Factors, Hemoglobinopathies and Related Disorders and Sexual Differentiation and Disorders.
- World rank
- #413,025 of 7,710,434 ranked researchers
- Rank in United States
- #146,108 of 1,627,098
- Works
- 117
- Citations
- 5.3k
- Citations per work
- 45.6
What does Kenneth M. Attie research?
Kenneth M. Attie's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (24%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5143.5%
- Medicine5143.5%
- Everything else3832.5%
- Life Sciences2824.0%
- 1Endocrinology, Diabetes and Metabolism20% of their works
- 2Molecular Biology18% of their works
- 3Hematology11% of their works
- 4Genetics9% of their works
- 5Genetics6% of their works
- 6Physiology4% of their works
Research topics
- Growth Hormone and Insulin-like Growth Factors
- Hemoglobinopathies and Related Disorders
- Sexual Differentiation and Disorders
- Acute Myeloid Leukemia Research
- TGF-β signaling in diseases
- Muscle Physiology and Disorders
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Blood groups and transfusion
Which keywords describe Kenneth M. Attie's research?
The keywords of their largest research topics: IGF-1, Insulin-like Growth Factors, Sickle-cell Disease, Thalassemia, Congenital Adrenal Hyperplasia, Steroid 21-Hydroxylase Deficiency, Acute Myeloid Leukemia and AML.
- X Chromosome Inactivation
- Blood Groups
- Skeletal Muscle Atrophy
- Tumor Suppression
- Acute Myeloid Leukemia
- Steroid 21-Hydroxylase Deficiency
- Thalassemia
- Insulin-like Growth Factors
- IGF-1
- Sickle-cell Disease
- Congenital Adrenal Hyperplasia
- AML
- Smad-dependent pathways
- Muscle Regeneration
- Alloimmunization
- Sex Determination
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- IGF-1371 topic
- Insulin-like Growth Factors371 topic
- Sickle-cell Disease181 topic
- Thalassemia181 topic
- Congenital Adrenal Hyperplasia171 topic
- Steroid 21-Hydroxylase Deficiency171 topic
- AML131 topic
- Acute Myeloid Leukemia131 topic
- Smad-dependent pathways121 topic
- Tumor Suppression121 topic
- Muscle Regeneration101 topic
- Skeletal Muscle Atrophy101 topic
- Alloimmunization91 topic
- Blood Groups91 topic
- Sex Determination91 topic
- X Chromosome Inactivation91 topic
Where does Kenneth M. Attie work?
Kenneth M. Attie's main affiliation in the publication record is Acceleron Pharma (United States), United States.
How many publications and citations does Kenneth M. Attie have?
OpenAlex counts 117 works and 5,334 citations for Kenneth M. Attie, an h-index of 37, ranking #413,025 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kenneth M. Attie. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.